Research Projects

At the Center for the Evaluation of Value and Risk in Health (CEVR), our current projects include:

  • Appraisal of the inter-country transferability of approaches to value assessment
  • Assessing diagnosis and treatment delays and health care disparities by race/ethnicity among individuals with Alzheimer’s disease and related dementias
  • Center of excellence in value assessment award
  • Clinical and economic value of whole exome sequencing (WES) in rare and undiagnosed diseases
  • Disinvestment opportunities for low-value care in commercially insured populations
  • Evaluating accuracy in health technology assessments
  • Examining lifetime costs and health benefits associate with chronic disease management
  • Examining the impact of breakthrough therapy designation on health plan coverage decisions
  • Exploring commercial health plan coverage of biosimilars
  • How comprehensive are health plans’ evidence reviews in specialty drug coverage decisions
  • Increasing the use of health economic information for global health
  • Is orphan drug coverage associated with cost-effectiveness? An empirical study 
  • Racial and ethnic disparities in ADRD diagnosis, treatment, and costs
  • The influence of ICER reports on payers’ specialty drug coverage: An empirical analysis.
  • The social value of vaccines: A new look
  • Value framework for major depression
  • When are breakthrough therapies cost-effective?